Vitro Biopharma Inc (DELISTED) (VTRO:DL)
Vitro Biopharma Gross Profit Margin (Quarterly): 83.23% for July 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2023 | 83.23% |
| April 30, 2023 | 79.65% |
| January 31, 2023 | 80.67% |
| October 31, 2022 | 63.49% |
| Date | Value |
|---|---|
| July 31, 2022 | 79.25% |
| April 30, 2022 | 86.89% |
| January 31, 2022 | 86.35% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
63.49%
Minimum
Oct 2022
86.89%
Maximum
Apr 2022
79.93%
Average
80.67%
Median
Jan 2023
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 74.85% |
| Xtant Medical Holdings Inc | 62.07% |
| Asensus Surgical Inc | -172.1% |
| Senseonics Holdings Inc | 6.64% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -345.0% |
| Return on Assets | -68.75% |
| Return on Invested Capital | -124.7% |
| Profit Margin (Quarterly) | -151.0% |
| Operating Margin (Quarterly) | -180.1% |
| Return on Net Operating Assets | -87.63% |